Jan Thomas Schäfer
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Jan Thomas Schäfer has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Daniel Herold
Chair for Industrial Organization, Regulation and Antitrust, Department of Economics, Justus Liebig University Giessen, Giessen, Germany
11 shared publications - Georg Götz
Justus-Liebig-Universität Giessen
8 shared publications - Phil-Adrian Klotz
Justus-Liebig-Universität Giessen
8 shared publications - Daniel Lüke
Justus-Liebig-Universität Giessen
7 shared publications - Johannes Paha
Justus-Liebig-Universität Giessen
7 shared publications - Maximilian M. Gail
Justus-Liebig-Universität Giessen
7 shared publications
Latest Publications
- Open Access
- 18 May 2026
- Published by Wiley in Health Economics
- Vol. 35 (8) , 1247-1274
Evaluation of a Partial Ban on Rx‐Rebates in Germany
We investigate patients' price sensitivity for prescription (Rx) drugs with regards to patronizing online or brick‐and‐mortar pharmacies. In doing so, we exploit a policy change in Germany that prohibited online pharmacies from granting rebates to one part of the population, the members of the statutory health insurance scheme. This policy change created a natural experiment, allowing us to analyze its impact on the pharmaceutical market using Difference‐in‐Differences (DiD). Utilizing a novel dataset obtained from merchandize information systems, we find that the ban led to a shift in consumer behavior, increasing offline pharmacy Rx sales by 1.42%–1.67%. In a second step, we assess to what extent the policy change achieved its alleged goal of supporting brick‐and‐mortar pharmacies. Our findings indicate that pharmacies with low revenues, which are most exposed to market exit, saw only a minor increase in annual revenues of around € 1587. At the same time, pharmacies in the highest decile gained roughly four times that amount. This indicates that the policy change alone was insufficient to reverse the declining trend in pharmacy numbers in Germany. To strengthen the comprehensive supply of pharmaceuticals to the general population, additional reforms seem necessary.
- 18 May 2026
- Published by Wiley in Health Economics
- Vol. 35 (8) , 1247-1274
Open AccessEvaluation of a Partial Ban on Rx‐Rebates in Germany
We investigate patients' price sensitivity for prescription (Rx) drugs with regards to patronizing online or brick‐and‐mortar pharmacies. In doing so, we exploit a policy change in Germany that prohibited online pharmacies from granting rebates to one part of the population, the members of the statutory health insurance scheme. This policy change created a natural experiment, allowing us to analyze its impact on the pharmaceutical market using Difference‐in‐Differences (DiD). Utilizing a novel dataset obtained from merchandize information systems, we find that the ban led to a shift in consumer behavior, increasing offline pharmacy Rx sales by 1.42%–1.67%. In a second step, we assess to what extent the policy change achieved its alleged goal of supporting brick‐and‐mortar pharmacies. Our findings indicate that pharmacies with low revenues, which are most exposed to market exit, saw only a minor increase in annual revenues of around € 1587. At the same time, pharmacies in the highest decile gained roughly four times that amount. This indicates that the policy change alone was insufficient to reverse the declining trend in pharmacy numbers in Germany. To strengthen the comprehensive supply of pharmaceuticals to the general population, additional reforms seem necessary.
- Open Access
- 20 February 2026
- Published by Elsevier in Transport Policy
- Vol. 181
Upstream vs. downstream grants — The role of public contributions in improving railway efficiency in Europe
- 20 February 2026
- Published by Elsevier in Transport Policy
- Vol. 181
Open AccessUpstream vs. downstream grants — The role of public contributions in improving railway efficiency in Europe
- Open Access
- 12 May 2025
- Published by Elsevier in Health Policy
- Vol. 157, 105332
Munich goes viral: Measuring the impact of the Oktoberfest on COVID-19 infection rates using difference-in-differences
- 12 May 2025
- Published by Elsevier in Health Policy
- Vol. 157, 105332
Open AccessMunich goes viral: Measuring the impact of the Oktoberfest on COVID-19 infection rates using difference-in-differences
- 12 March 2023
- Published by Springer Nature
- p. 67-78
Staatliche Eingriffe durch Lenkungssteuern: Der Verkehrssektor
- 12 March 2023
- Published by Springer Nature
- p. 67-78
Staatliche Eingriffe durch Lenkungssteuern: Der Verkehrssektor
- 12 March 2023
- Published by Springer Nature
- p. 5-11
Marktversagen und -eingriffe
- 12 March 2023
- Published by Springer Nature
- p. 27-48
Preisregulierung und nichtlineare Tarife: Der Gasmarkt
- 12 March 2023
- Published by Springer Nature
- p. 27-48
Preisregulierung und nichtlineare Tarife: Der Gasmarkt
- 12 March 2023
- Published by Springer Nature
- p. 49-66
Staatliche Eingriffe zur Erfüllung der Daseinsvorsorge: Der öffentliche Personennahverkehr
- 12 March 2023
- Published by Springer Nature
- p. 49-66
Staatliche Eingriffe zur Erfüllung der Daseinsvorsorge: Der öffentliche Personennahverkehr
- 12 March 2023
- Published by Springer Nature
- p. 13-26
Höchstpreise und lineare Tarife: Der Wohnungsmarkt
- 12 March 2023
- Published by Springer Nature
- p. 1-3
Einleitung